Retrospective Cohort Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Apr 16, 2021; 9(11): 2446-2457
Published online Apr 16, 2021. doi: 10.12998/wjcc.v9.i11.2446
Table 2 Outcomes by timing of computed tomography imaging
Total
Urgent CT
Elective CT
P value
n = 182
n = 100
n = 82
Extravasation-positive rate, n (%)67 (36.8)47 (47.0)20 (24.4)< 0.01
SRH identification, n (%)41 (22.5)35 (35.0)6 (7.3)< 0.01
Active bleeding30 (16.5)26 (26.0)4 (4.9)< 0.01
Adherent clot7 (3.8)6 (6.0)1 (1.2)0.06
Non-bleeding visible vessel4 (2.2)3 (3.0)1 (1.2)0.32
Hospitalization length of stay, d, mean ± SD7.4 ± 5.37.1 ± 4.17.7 ± 6.30.40
Need for interventional radiology, n (%)4 (2.2)1 (1.0)3 (3.7)0.48
Need for surgery, n (%)4 (2.2)0 (0.0)4 (4.9)0.08
Blood transfusion, n (%)40 (22.0)24 (24.0)16 (19.5)0.61
Amount of transfusion, units, mean ± SD1.1 ± 2.71.2 ± 2.61.0 ± 2.80.46
Blood transfusion after SRH, n (%)17 (9.3)13 (13.0)4 (4.9)0.11
Contrast media-related adverse events
Nausea, vomiting n (%)1 (0.6)1 (1.0)0
Urticaria and skin rash, n (%)000
Pruritus, n (%)1 (0.6)01 (1.2)
Erythema, n (%)000
Laryngeal edema, n (%)000
Sneezing, n (%)000
Coughing, n (%)000
Contrast media-related severe adverse events
Dyspnea, n (%)000
Sudden drop in blood pressure, n (%)000
Loss of consciousness, n (%)000
Cardiac arrest, n (%)000